1. RETRACTED: TRAF4 promotes endometrial cancer cell growth and migration by activation of PI3K/AKT/Oct4 signaling
   Pengmu Xie et al, 2019, Experimental and Molecular Pathology CrossRef
2. Pathophysiological Integration of Metabolic Reprogramming in Breast Cancer
   Roberto Corchado-Cobos et al, 2022, Cancers CrossRef
3. Pir2/Rnf144b is a potential endometrial cancer biomarker that promotes cell proliferation
   Qing Zhou et al, 2018, Cell Death & Disease CrossRef
4. Therapeutic targeting of replicative immortality
   Paul Yaswen et al, 2015, Seminars in Cancer Biology CrossRef
5. Regulation of epithelial–mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs
   C. N. Kent et al, 2016, Clinical and Translational Oncology CrossRef
6. Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance
   Eylem Kulkoyluoglu-Cotul et al, 2019, Cancers CrossRef
7. ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells
   Nan Zheng et al, 2015, Journal of Pharmacological Sciences CrossRef
8. Estrogen-like neuroprotection of isopsoralen against spinal cord injury through estrogen receptor ERα
   Xiao-ming Li et al, 2017, Metabolic Brain Disease CrossRef
9. The effects of bisphenol A, benzyl butyl phthalate, and di(2-ethylhexyl) phthalate on estrogen receptor alpha in estrogen receptor-positive cells under hypoxia
   Choa Park et al, 2019, Environmental Pollution CrossRef
10. A guide for endometrial cancer cell lines functional assays using the measurements of electronic impedance
    Joanna Kozak et al, 2018, Cytotechnology CrossRef
11. An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer
    Hephzibah Cathryn R. et al, 2023, Journal of Cellular Biochemistry CrossRef
12. The Role of Obesity in the Etiology and Carcinogenesis of Endometrial Cancer
    Alina-Gabriela Marin et al, 2024, Cureus CrossRef
13. Estrogen promotes fat mass and obesity-associated protein nuclear localization and enhances endometrial cancer cell proliferation via the mTOR signaling pathway
    YAPING ZHU et al, 2016, Oncology Reports CrossRef
14. Signal Pathway of Estrogen and Estrogen Receptor in the Development of Thyroid Cancer
    Jian Liu et al, 2021, Frontiers in Oncology CrossRef
15. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification
    Wan Shu et al, 2022, Drug Design, Development and Therapy CrossRef
16. The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
    Tatiana S. Driva et al, 2022, International Journal of Molecular Sciences CrossRef
17. The Metabolic Mechanisms of Breast Cancer Metastasis
    Lingling Wang et al, 2021, Frontiers in Oncology CrossRef
18. Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis
    Hsiao-Chen Chiu et al, 2019, Journal of Clinical Medicine CrossRef
19. Mevastatin ameliorates sphingosine 1‐phosphate‐induced COX‐2/PGE2‐dependent cell migration via FoxO1 and CREB phosphorylation and translocation
    Chih‐Kai Hsu et al, 2015, British Journal of Pharmacology CrossRef
20. Estrogen inhibits autophagy and promotes growth of endometrial cancer by promoting glutamine metabolism
    Wen-Jie Zhou et al, 2019, Cell Communication and Signaling CrossRef
21. Roles of estrogen receptor α in endometrial carcinoma (Review)
    Yidong Ge et al, 2023, Oncology Letters CrossRef
22. Urocortin suppresses endometrial cancer cell migration via CRFR2 and its system components are differentially modulated by estrogen
    Gemma L. Owens et al, 2017, Cancer Medicine CrossRef
23. BIOINFORMATICS ANALYSIS OF MOLECULAR CHARACTERISTICS OF ENDOMETRIAL AND BREAST CANCER ASSOCIATED WITH ESR1
    null null et al, 2023, Oncology CrossRef
24. The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies
    Javier Cortés et al, 2017, Cancer Treatment Reviews CrossRef
25. Obesity Epidemic—The Underestimated Risk of Endometrial Cancer
    Ludwig Kiesel et al, 2020, Cancers CrossRef
26. Future perspectives for mTOR inhibitors in renal cell cancer treatment
    Anna M Czarnecka et al, 2015, Future Oncology CrossRef
27. Expression of G protein‐coupled oestrogen receptor in melanoma and in pregnancy‐associated melanoma
    M. Fábián et al, 2017, Journal of the European Academy of Dermatology and Venereology CrossRef
28. Effect of PI3K/Akt/mTOR signaling pathway on JNK3 in Parkinsonian rats
    Ying Chen et al, 2018, Experimental and Therapeutic Medicine CrossRef
29. The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review
    Klaudia Klicka et al, 2021, Cancers CrossRef